ADAM32 | ADAM metallopeptidase domain 32 | Enzymes Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enriched |
ADAM33 | ADAM metallopeptidase domain 33 | Disease related genes Enzymes Potential drug targets Predicted membrane proteins Predicted secreted proteins
| | | | | Mixed |
ADAM7 | ADAM metallopeptidase domain 7 | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted membrane proteins Predicted secreted proteins
| | | | | Not detected |
ADAM8 | ADAM metallopeptidase domain 8 | CD markers Enzymes Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
ADAM9 | ADAM metallopeptidase domain 9 | Cancer-related genes Disease related genes Enzymes Plasma proteins Potential drug targets Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
ADAMTS1 | ADAM metallopeptidase with thrombospondin type 1 motif, 1 | Cancer-related genes Enzymes Plasma proteins Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
ADCK2 | AarF domain containing kinase 2 | Enzymes Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
ADCK5 | AarF domain containing kinase 5 | Enzymes Predicted membrane proteins
| | | | | Mixed |
ADCY1 | Adenylate cyclase 1 (brain) | Cancer-related genes Disease related genes Enzymes Potential drug targets Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enriched |
ADCY10 | Adenylate cyclase 10 (soluble) | Cytoskeleton related proteins Disease related genes Enzymes Potential drug targets Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enriched |
ADCY2 | Adenylate cyclase 2 (brain) | Enzymes Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
ADCY3 | Adenylate cyclase 3 | Enzymes Plasma proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
ADCY4 | Adenylate cyclase 4 | Enzymes Plasma proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Mixed |
ADCY5 | Adenylate cyclase 5 | Disease related genes Enzymes Potential drug targets Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
ADCY6 | Adenylate cyclase 6 | Enzymes Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
ADCY7 | Adenylate cyclase 7 | Enzymes Predicted intracellular proteins Predicted membrane proteins
| | | | | Mixed |
ADCY8 | Adenylate cyclase 8 (brain) | Enzymes Predicted intracellular proteins Predicted membrane proteins
| | | | | Group enriched |
ADCY9 | Adenylate cyclase 9 | Enzymes Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
ADCYAP1R1 | Adenylate cyclase activating polypeptide 1 (pituitary) receptor type I | G-protein coupled receptors Predicted membrane proteins Predicted secreted proteins Transporters
| | | | | Group enriched |
ADIG | Adipogenin | Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enriched |
ADIPOR1 | Adiponectin receptor 1 | Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
ADIPOR2 | Adiponectin receptor 2 | Predicted membrane proteins
| | | | | Expressed in all |
ADORA1 | Adenosine A1 receptor | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
ADORA3 | Adenosine A3 receptor | FDA approved drug targets G-protein coupled receptors Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
ADPRM | ADP-ribose/CDP-alcohol diphosphatase, manganese-dependent | Enzymes Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
ADRA1A | Adrenoceptor alpha 1A | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
ADRA1D | Adrenoceptor alpha 1D | FDA approved drug targets G-protein coupled receptors Plasma proteins Predicted membrane proteins
| | | | | Tissue enhanced |
ADRA2B | Adrenoceptor alpha 2B | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| | | | | Mixed |
ADRA2C | Adrenoceptor alpha 2C | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
ADRB1 | Adrenoceptor beta 1 | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
ADRB2 | Adrenoceptor beta 2, surface | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins Transporters
| | | | | Mixed |
ADTRP | Androgen-dependent TFPI-regulating protein | Predicted membrane proteins
| | | | | Tissue enhanced |
AFG3L2 | AFG3-like AAA ATPase 2 | Disease related genes Enzymes Mitochondrial proteins Plasma proteins Potential drug targets Predicted membrane proteins
| | | | | Expressed in all |
AGER | Advanced glycosylation end product-specific receptor | Cancer-related genes Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enriched |
AGL | Amylo-alpha-1, 6-glucosidase, 4-alpha-glucanotransferase | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted membrane proteins
| | | | | Expressed in all |
AGMO | Alkylglycerol monooxygenase | Enzymes Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
AGPAT2 | 1-acylglycerol-3-phosphate O-acyltransferase 2 | Disease related genes Enzymes Potential drug targets Predicted membrane proteins
| | | | | Expressed in all |
AGPAT4 | 1-acylglycerol-3-phosphate O-acyltransferase 4 | Enzymes Predicted intracellular proteins Predicted membrane proteins
| | | | | Mixed |
AGPAT5 | 1-acylglycerol-3-phosphate O-acyltransferase 5 | Enzymes Predicted membrane proteins
| | | | | Expressed in all |
AGPAT6 | 1-acylglycerol-3-phosphate O-acyltransferase 6 | Enzymes Predicted membrane proteins
| | | | | Expressed in all |
AGPAT9 | 1-acylglycerol-3-phosphate O-acyltransferase 9 | Enzymes Predicted membrane proteins
| | | | | Tissue enhanced |
AGTR1 | Angiotensin II receptor, type 1 | Disease related genes FDA approved drug targets G-protein coupled receptors Predicted membrane proteins Transporters
| | | | | Group enriched |
AGTRAP | Angiotensin II receptor-associated protein | Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
AIFM1 | Apoptosis-inducing factor, mitochondrion-associated, 1 | Disease related genes Mitochondrial proteins Plasma proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
AIG1 | Androgen-induced 1 | Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
AJAP1 | Adherens junctions associated protein 1 | Predicted membrane proteins
| | | | | Tissue enhanced |
AKAP1 | A kinase (PRKA) anchor protein 1 | Mitochondrial proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
AKAP6 | A kinase (PRKA) anchor protein 6 | Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
AKAP9 | A kinase (PRKA) anchor protein 9 | Cancer-related genes Cytoskeleton related proteins Disease related genes Plasma proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
ALCAM | Activated leukocyte cell adhesion molecule | Cancer-related genes CD markers Plasma proteins Predicted membrane proteins
| | | | | Mixed |